TY  - CONF
AU  - Zeljković, Aleksandra
AU  - Vekić, Jelena
AU  - Jelić-Ivanović, Zorana
AU  - Spasojević-Kalimanovska, Vesna
AU  - Spasić, S.
AU  - Simić-Ogrizović, Sanja
AU  - Dopsaj, Violeta
PY  - 2010
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1407
PB  - Elsevier Ireland Ltd, Clare
C3  - Atherosclerosis Supplements
T1  - Small-sized high-density lipoprotein particles are associated with reduced survival rate in end-stage renal disease patients
VL  - 11
IS  - 2
SP  - 215
EP  - 215
DO  - 10.1016/S1567-5688(10)71025-4
UR  - conv_2319
ER  - 

@conference{
author = "Zeljković, Aleksandra and Vekić, Jelena and Jelić-Ivanović, Zorana and Spasojević-Kalimanovska, Vesna and Spasić, S. and Simić-Ogrizović, Sanja and Dopsaj, Violeta",
year = "2010",
publisher = "Elsevier Ireland Ltd, Clare",
journal = "Atherosclerosis Supplements",
title = "Small-sized high-density lipoprotein particles are associated with reduced survival rate in end-stage renal disease patients",
volume = "11",
number = "2",
pages = "215-215",
doi = "10.1016/S1567-5688(10)71025-4",
url = "conv_2319"
}

Zeljković, A., Vekić, J., Jelić-Ivanović, Z., Spasojević-Kalimanovska, V., Spasić, S., Simić-Ogrizović, S.,& Dopsaj, V.. (2010). Small-sized high-density lipoprotein particles are associated with reduced survival rate in end-stage renal disease patients. in Atherosclerosis Supplements
Elsevier Ireland Ltd, Clare., 11(2), 215-215.
https://doi.org/10.1016/S1567-5688(10)71025-4
conv_2319

Zeljković A, Vekić J, Jelić-Ivanović Z, Spasojević-Kalimanovska V, Spasić S, Simić-Ogrizović S, Dopsaj V. Small-sized high-density lipoprotein particles are associated with reduced survival rate in end-stage renal disease patients. in Atherosclerosis Supplements. 2010;11(2):215-215.
doi:10.1016/S1567-5688(10)71025-4
conv_2319 .

Zeljković, Aleksandra, Vekić, Jelena, Jelić-Ivanović, Zorana, Spasojević-Kalimanovska, Vesna, Spasić, S., Simić-Ogrizović, Sanja, Dopsaj, Violeta, "Small-sized high-density lipoprotein particles are associated with reduced survival rate in end-stage renal disease patients" in Atherosclerosis Supplements, 11, no. 2 (2010):215-215,
https://doi.org/10.1016/S1567-5688(10)71025-4 .,
conv_2319 .